Actionable insights straight to your inbox

Equities logo

Everything’s Going Right For Invictus as an Emerging Leader in the Cannabis Business

Almost immediately after Canada's landmark decision to legalize cannabis, Invictus made a number of major announcements of its own.

July is shaping up to be full of significant developments for Invictus MD Strategies GENE:CA(OTC: IVITF). With the Canadian government making history on June 20 by legalizing recreational marijuana — effective October 17 — the timing couldn’t be better for the Vancouver-based company to expand its cultivation footprint, broaden its strain portfolio, forge a new major brand partnership and land the province of British Columbia as a customer.

More Green Acres

Invictus owns 50% of AB Laboratories, a licensed producer under Canada’s Access to Cannabis for Medical Purposes Regulations (AMCPR). Invictus also has an ownership interest in AB Ventures, which has 100 acres of land in Hamilton, Ontario, to be used for future cannabis cultivation. A 16,000-square-foot, state-of-the-art cultivation space has been completed and is operating at full capacity, with Phase 2 of the project progressing as scheduled to add another 40,000 square feet of grow space.

This month, Invictus added another acre of land adjacent to the property at AB laboratories, earmarking it for additional expansion to the property.

This is a solid addition for Invictus, following a recent letter of intent to acquire another cannabis cultivation company awaiting its production license from Health Canada. When construction of the current planned facilities is complete – without accounting for the extra acre – Invictus will have 915,000 square feet of production capacity by the end of 2019.

AB Labs is going to need the extra cultivation space to keep up with its rapidly growing portfolio of elite strains of cannabis. Leveraging AB Labs’ partner in the Netherlands this month, the company’s portfolio now holds more than 40 strains, including a host of indica dominant, sativa dominant and indica/sativa hybrid selections.

Leveraging Iconic Brands and Influencers

Furthermore, Invictus recently struck a deal with global brand owner and marketing firm Authentic Brands Group (ABG). New York City-based ABG is a world-renowned outfit with a portfolio of more than 30 iconic brands that already have a substantial market presence spanning the celebrity and entertainment, luxe, fashion, street and active lifestyle sectors. The company owns and manages household brands including Aeropostale, Elvis Presley, Above the Rim, Muhammad Ali, Shaquille O’Neal, Nautica and many more.

The plan is for Invictus to cull through ABG’s existing portfolio to unlock hidden potential to develop products for these brands that naturally dovetail into the cannabis marketplace. Moreover, ABG’s extensive branding experience will be invaluable in potentially launching an entirely new brand in the legal marijuana space.

The licensing and marketing agreement lays out the framework for the companies to collaborate and launch new cannabis products, including dried flower, and oils and concentrates, into the exploding Canadian recreational and medicinal markets first, with intentions for international expansion in the future.

An integrated company, Invictus will commercialize the products through its wholly-owned and fully-licensed producer, Alberta-based Acreage Pharms Ltd.

“We are constantly looking for ways to innovate and activate some of the more specialized intellectual property within the ABG portfolio,” commented ABG Chief Executive and Chairman Jamie Salter in the press release on the partnership. “We’ve recognized that cannabis is a growing product category within the health, wellness and lifestyle spaces, and our partnership with Invictus allows us to test the waters in this important, emerging market.”

Broadly speaking about the recent developments, Invictus CEO Dan Kriznic summed things up succinctly in a press release on July 9, saying, “Expanding both our cultivation space and strain selection is key to driving growth in a sector that will see increasing demand from both the public and private sector. By constructing state-of-the-art production and processing facilities, our team of award-winning horticulturalists can continue to innovate and deliver high-quality products that consumers can trust.”

Milestone Deal with British Columbia

Invictus already has one of the world’s most high-profile cannabis customers in industry heavyweight Canopy Growth Corp. CGC(WEED:CA) and recently transferred its second 63-kilogram batch of dried cannabis to Canopy Growth’s Tweed’s elite CraftGrow line.

On July 11, the company announced it signed a memorandum of understanding with the British Columbia Liquor Distribution Branch (LDB) for Acreage Pharms to supply the province with a selection of premium cannabis products for the upcoming recreational marketplace. The agreement represents a milestone for Invictus, as this is its first supply agreement with a province.

A definitive deal is being hashed out that meets mutual objectives of B.C. and Invictus to build a safer cannabis marketplace while supporting economic growth in Canada.

The agreement falls in line with the company’s diverse sales and distribution strategy, as exemplified by the agreements with Canopy Growth, ABG, AB Labs and initiatives to open retail locations throughout western Canada with intentions for worldwide distribution.

In the interest of full disclosure, we call the reader’s attention to the fact that, Inc. is compensated by the companies profiled in the Spotlight Companies section. The purpose of these profiles is to provide awareness of these companies to investors in the micro, small-cap and growth equity community and should not in any way be considered as a recommendation to buy, sell or hold these securities. is not a registered broker dealer, investment advisor, financial analyst, investment banker or other investment professional. We are a publisher of original and third party news and information. All profiles are based on information that is available to the public. The information contained herein should not be considered to be complete and is not guaranteed by to be free from misstatement or errors. The views expressed are our own and not intended to be the basis for any investment decision. Readers are reminded to do their own due diligence when researching any companies mentioned on this website. Always bear in mind that investing in early-stage companies is risky and you are encouraged to only invest an amount that you can afford to lose completely without any change in your lifestyle. Equities has been compensated with cash, common shares and/or warrants for market awareness services provided.

A weekly five-point roundup of critical events in fintech, the future of finance and the next wave of banking industry transformation.